December 9, 2022 /

Webinar: A Conversation with PTC Therapeutics (December 2022)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

PTC Therapeutics joined PPMD for a community webinar on December 9, 2022 for a discussion regarding PTC’s history with the community and plans for the future, including activities to bring ataluren (Translarna) to US patients with nonsense mutations.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo